WO2002006304A1 - Process for the preparation of dipeptide derivatives - Google Patents

Process for the preparation of dipeptide derivatives Download PDF

Info

Publication number
WO2002006304A1
WO2002006304A1 PCT/EP2001/007067 EP0107067W WO0206304A1 WO 2002006304 A1 WO2002006304 A1 WO 2002006304A1 EP 0107067 W EP0107067 W EP 0107067W WO 0206304 A1 WO0206304 A1 WO 0206304A1
Authority
WO
WIPO (PCT)
Prior art keywords
process according
group
formula
solvent
base
Prior art date
Application number
PCT/EP2001/007067
Other languages
French (fr)
Inventor
Giovanni Camaggi
Marilena Gusmeroli
Silvia Mormile
Alexia Elmini
Original Assignee
Isagro Ricerca S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isagro Ricerca S.R.L. filed Critical Isagro Ricerca S.R.L.
Priority to AU2001270584A priority Critical patent/AU2001270584A1/en
Publication of WO2002006304A1 publication Critical patent/WO2002006304A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Definitions

  • the dipeptide (VII) thus obtained is reacted in dichlo- ro ethane with an alkylchloroformate (III) to give the com ⁇ pounds having formula (I) .
  • the buffer at pH 10 can be selected from potassium borate, sodium borate, sodium phosphate, potassium phosphate.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process is described for the preparation of dipeptide derivatves having formula (I) characterized by reaction scheme (II).

Description

PROCESS FOR THE PREPARATION OF DIPEPTIDE DERIVATIVES
The present invention relates to a new process for the preparation of dipeptide derivatives capable of effectively controlling phytopathogens of crops of agronomic interest.
Italian patent application MI98A02583 describes dipeptide compounds having a high antifungine activity and a process for their preparation.
In particular, the above patent application describes dipeptide compounds having formula (I)
Figure imgf000002_0001
obtained according to the following reaction scheme (1!
Figure imgf000003_0001
(II) (111)
Figure imgf000003_0002
(IV) (V)
SCHEMA 1
In practice, the N-alkoxycarbonyl-L-valine (II) , obtained by the condensation of L-valine with an alkylchloroformate (III), is reacted with a second mole of an alkylchloroformate (III), to give the mixed anhydride having formula (IV). The aminoester (V) is then added to give the desired compound having formula (I) . Patent application MI98A02583 also describes that the compounds having formula (I) can be obtained according to the following alternative reaction scheme (Scheme 2) :
Figure imgf000004_0001
(VI) (V)
Figure imgf000004_0002
(VII)
SCHEMA 2
wherein the 4-isopropyl-oxazolidin-2, 5-dione (VI), obtained as described in Chemistry Letters (1973) pages 1143-1144 and Journal of American Chemical Society (1971) _93 page 2746, is reacted with the aminoester (V) in great excess or in an equimolecular quantity but in the presence of an organic or inorganic base.
The dipeptide (VII) thus obtained is reacted in dichlo- ro ethane with an alkylchloroformate (III) to give the com¬ pounds having formula (I) .
The first reaction scheme has quite a complex synthesis method due to the operating conditions and, above all, owing to the recovery of the desired product with high yields and a good degree of purity.
A second mole of alkylchloroformate (III) is also required for activating the carboxyl group of (II) , which not only increases the cost of the raw materials, but also necessitates additional processing for removing the corresponding alcohol which is formed during the reaction.
The second reaction scheme requires, for the formation of (VII), the presence, in excess, of a base, which partly favours the opening and polymerization of the anhydride (VI), with a significant lowering of the yield to the desired product (I) .
A process has now been found, which allows the compounds having formula (I) to be obtained with overall high yields, a high chemical purity and shorter reaction times.
In particular, an object of the present invention relates to a process for the preparation of dipeptide compounds having formula (I)
Figure imgf000005_0001
Ri represents a linear or branched Cχ-Cs alkyl group;
R2 represents a linear or branched Cι-C8 alkyl group;
R3 represents a group selected from a chlorine atom, a fluorine atom, a methyl group, an ethyl group, a eth- oxyl group, a cyano group; characterized in that an oxazolidinedione having formula (VI) is reacted with an alkylchloroformate having formula (III) to give an N-alkoxycarbonyloxazolidinedione having formula (VIII) which is subsequently reacted with an aminoester having formula (V) to give the compounds having formula (I) , according to the following reaction scheme (SCHEME 3) :
Figure imgf000006_0001
(VI) (III) (VIII)
Figure imgf000006_0002
(VIII) (V)
SCHEMA 3 The configuration of the chiral atom of the valine residue present in all the compounds having formula (I) is
S, according to the Ca n, Ingold and Prelog convention; the configuration of the chiral atom of the aromatic residue can be RS, S or R.
With respect to the process of SCHEME 1, the process of the present invention does not require the activation of the carboxyl group of compound (II) thus saving a mole of alkylchloroformate and with the absence of the corresponding al- cohol by-product.
Compared to the procedure of SCHEME 2, the process of the present invention differs in the order in which the cpm- pounds (VI) , (III) , (V) are reacted and it has the advantage of providing better yields on the whole, under simplified operating conditions during both the reaction and processing.
The process of the invention also requires the use of a single mole of base, with an additional saving and without any risk of racemization of the valine residue. This means it can also be used for the synthesis of optically active compounds at both chiral centres .
In step A, the anhydride (VI) is transformed into compound (VIII) by the addition of a suitable alkylchloroformate (III) in the presence of a tertiary organic base such as triethylamine, N-methyldioctylamine, methylpyridine, 4- (dimethylamino) pyridine, pyridine, N,N-dimethylbenzylamine,
N-methylmorpholine, N-ethylmorpholine, N-methylthiomorph- oline, N-ethylthiomorpholine, preferably N-methylmorph- oline, N-ethylmorpholine, N-methylthiomorpholine, N- ethylthiomorpholine.
The latter, in fact, have a p which is such as to allow the reaction with the alkylchloroformate of interest without causing the polymerization of (VI) .
The reaction can be carried out in an organic medium such as dichloromethane, trichloromethane, carbon tetrachlo- ride, ethyl acetate, tetrahydrofuran, dioxane, ethyl ether, toluene, N,N-dimethylformamide, dimethylsulfoxide; or it can be effected in an aqueous medium at pH 10 by means of a buffer such as, for example, potassium borate, sodium bo- rate, sodium carbonate, sodium phosphate, potassium phosphate, under stirring and at a temperature ranging from - 60°C to the boiling point of the solvent used as described in U.S. 5,028,693 and Synthetic Communication (1998) 2J3 pages 2713-2724. The preferred solvents are tetrahydrofuran, dioxane, dichloromethane and ethyl acetate at temperatures ranging from 0 to 30°C.
The preferred buffer is potassium borate.
The anhydrides (VIII) obtained when Ri has the pre- ferred meanings of iso-propyl and sec-butyl, are not known and therefore form a further object of the present invention.
In step B, the N-alkoxycarbonyloxazolidinedione having formula (VIII) is reacted with the aminoester (V) in the ab- sence or in the presence of an inorganic base such as, for example, potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, sodium hydroxide, potassium hydroxide.
Alternatively, a tertiary base can be used, such as, for example, triethylamine, N-methyldioctylamine, N- methylmorpholine, N-ethylmorpholine, N-methylthiomorph- oline, N-ethylthiomorpholine, pyridine, methylpyridine, 4- (dimethylamino) pyridine, N,N-dimethylbenzylamine .
The reaction is carried out in an organic solvent such as ethyl acetate, dichloromethane, trichloromethane, carbon tetrachloride, tetrahydrofuran, dioxane, ethyl ether, toluene, xylene, chlorobenzene, N,N-dime hylfor amide, dimethyl- sulfoxide at a temperature ranging from -65°C to the boiling point of the solvent used, as described in "Houben Weyl" 15/2, page 187 onwards.
The preferred solvents are dichloromethane, ethyl acetate, tetrahydrofuran; the bases selected are potassium carbonate, N-methylmorpholine; the preferred operating temperatures range from 0 to 30°C. A further advantage of the process described herein re- lates to the possibility of effecting steps A and B of SCHEME 3 in sequence, without isolating the intermediate (VIII) , in a single organic medium such as ethyl acetate, dichloromethane, trichloromethane, carbon tetrachloride, tetrahydrofuran, dioxane, ethyl ether, toluene, xylene, chlorobenzene, N,N-dimethylformamide, dimethylsulfoxide.
The reaction is carried out at a temperature ranging from -65°C to the boiling point of the solvent used, in the presence of a tertiary organic base such as triethylamine, N-methyldioctylamine, N-methylmorpholine, N-ethylmorpholine, N-methylthiomorpholine, N-ethylthiomorpholine, pyridine, methylpyridϊne, 4- (dimethylamino) pyridine, N,N- dimethylbenzylamine .
The preferred solvents are dichlorome hane, ethyl ace- tate, tetrahydrofuran; the bases are selected from N- methylmorpholine, N-ethylmorpholine, N-methylthiomorpholine, N-ethylthiomorpholine; the preferred operating temperatures range from 0 to 30°C
Alternatively, the reactions of steps A and B of SCHEME 3 can be carried out in sequence and without isolating the intermediate (VIII), in an aqueous medium in the presence of an inorganic base or a tertiary base, or a buffer at pH 10 and optionally in the presence of a co-solvent such as ethyl acetate, dichloromethane, trichloromethane, carbon tetra- chloride, tetrahydrofuran, dioxane, ethyl ether, toluene, xylene, chlorobenzene, N,N-dimethylformamide, dimethylsul- foxide, terbutyl ethylether, ter-amyl ethylether.
The inorganic base can be selected from potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bi- carbonate, sodium hydroxide, potassium hydroxide; the tertiary base can be selected from N-methyImorpholine, N- ethylmorpholine, N-methylthiomorpholine, N-ethylthiomorpholine, triethylamine, or N-methyldioctylamine or, pyridine, methylpyridine, 4- (dimethylamino) pyridine, N,N- dimethyIbenzylamine.
The buffer at pH 10 can be selected from potassium borate, sodium borate, sodium phosphate, potassium phosphate.
The reaction temperature generally ranges from -65°C to the boiling point of the solvent used. The preferred co-solvents are dichloromethane, ethyl acetate, tetrahydrofuran; the bases are selected from potassium carbonate and sodium hydroxide; the preferred buffer at pH 10 is potassium borate; the preferred operating temperatures range from 0 to 30°C. If desired, it is also possible to carry out steps A and B of the process in sequence, directly in the medium in which the oxazolidinedione having formula (VI) has been prepared, without isolating it, with a consequent additional simplification of the process and cost reduction. The following examples have the sole purpose of illus- trating the present invention but do not limit its scope in any way. EXAMPLE 1
Preparation of isopropyl 4-isopropyl-2,5-dioxa-3-oxazolid- inecarboxylate
70 g (67.3 ml) of isopropylchloroformate are added to a solution of 54.5 g of 4-isopropyloxazolidine-2, 5-dione in ethyl acetate (2000 ml) . The reaction mixture is cooled to 0°C, 58 g (63 ml) of N-methylmorpholine are added dropwise and the mixture is maintained at this temperature for 1.5 h. After letting the temperature rise to room values, the reaction is left under stirring for a night. The solid present is filtered and the organic solution is evaporated at reduced pressure. The raw product thus obtained is washed with hexane to obtain, after drying in air, 84.7 g of isopropyl 4-isopropyl-2, 5-dioxa-3-oxazolidinecarboxylate. Yield 97%. The compound is characterized by the following spectroscopic data: NMR λE (200 MHz) in CDC13: 0.95 (3H, d) , 1.19 (3H, d) , 1.38 (6H, dd) , 2.53 (1H, m) , 4.58 (1H, d) , 5.1 (1H, m) . EXAMPLE 2
Preparation of sec-butyl 4-isopropyl-2, 5-dioxa-3-oxazolid- inecarboxylate .
The desired compound is obtained with a procedure and preparative scale analogous to that described in example 1, using sec-butylchloroformate. Yield 95%.
The compound is characterized by the following spectroscopic data:
NMR E (200 MHz) in CDC13. 0.60 (3H, t) , 0.96 (3H, d) , 1.18 (3H, d) , 1.32 (3H, d) , 1.4 (2H, m) , 2.52 (1H, m) , 4.55 (1H, d) , 4.7 (1H, ) . EXAMPLE 3
Preparation of (±) RS- [3- (N-isopropσxycarbonyl-S-valinyl) - amino]-3- (4-chlorophenyl) ethyl propanoate.
93 g of (±) RS-3-amino-3- (4-chlorophenyl) ethyl propanoate dissolved in dichloromethane (300 ml) are rapidly added dropwise to a solution of 100 g of isopropyl 4- isopropyl-2, 5-dioxa-3-oxazolidinecarboxylate in dichlo¬ romethane (400 ml) , cooled to 0°C. After letting the tem- perature rise to room values, the reaction is left under stirring for 1 hour. The reaction mixture is concentrated to minimum volume at reduced pressure and subsequently poured into a large volume of hexane kept under vigorous stirring. The white crystal which is separated, is collected by fil- tration, is then washed with additional hexane to obtain, after drying in air, 170 g of (+) RS- [3- (N-isopropoxy- carbonyl-S-valinyl) -amino] -3- (4-chlorophenyl) -me-thyl propanoate. Yield 98%.
The compound is characterized by the following spectroscopic data: NMR XH (200 MHz) in CDC13: 0.95 (6H, m) , 1.19 (6H, ) , 2.1 (1H, ) , 2.8 (2H, t) , 3.65 (3H, d) , 4.0 (1H, m) , 4.85 (1H, m) , 5.35 (2H, m) , 7.3 (5H, m) .
[ ]D 25°c (c = 1, CH2C12) : -12.5° GC-MS: 398 (M+) , 212, 158, 116 (100%), 72.

Claims

A process for the preparation of dipeptide compounds having formula (I) :
Figure imgf000015_0001
( i ; wherein
Ri represents a linear or branched Cx-Cs alkyl group;
R2 represents a linear or branched Cι-C8 alkyl group;
R3 represents a group selected from a chlorine atom, a fluorine atom, a methyl group, an ethyl group, a methoxyl group, a cyano group; characterized in that an oxazolidinedione having formula (VI) is reacted with an alkylchloroformate having formula (III) to give an N-alkoxycarbonyloxazolid- inedione having formula (VIII) which is subsequently reacted with an aminoester having formula (V) to give the compounds having formula (I) , according to the following reaction scheme (3) :
Figure imgf000016_0001
(VI) (III) (VIII)
Figure imgf000016_0002
SCHEMA 3
Intermediate compounds consisting of N-alkoxycarbonyl- oxazolidinedione having formula (VIII) wherein Ri is iso-propyl or sec-butyl.
The process according to claim 1, wherein the transformation reaction of the anhydride (VI) in compound (VIII) is effected in an organic solvent in the presence of a tertiary organic base or in an aqueous medium buffered at pH 10, at a temperature ranging from -60°C to the boiling point of the solvent used. The process according to claim 3, wherein the tertiary organic base is selected from the group consisting of N-methyImorpholine^ N-ethylmorpholine, N-methylthio- morpholine, N-ethylthiomorpholine.
5. The process according to claim 3, wherein the organic solvent is selected from tetrahydrofuran, dioxane, dichloromethane, ethyl acetate and the temperature ranges from 0 to 30°C. 6. The process according to claim 3, wherein the aqueous medium is buffered with potassium borate.
7. The process according to claim 1, wherein the N- alkoxycarbonyloxazolidinedione having formula (VIII) is reacted with the aminoester (V) in an organic solvent, optionally in the presence of an inorganic base or a tertiary base, at a temperature ranging from -65°C to the boiling point of the solvent used.
8. The process according to claim 7, wherein the solvent is selected from the group consisting of dichlo- romethane, ethyl acetate, tetrahydrofuran.
9. The process according to claim 7, wherein the base is selected from the group consisting of potassium carbonate, N-methylmorpholine.
10. The process according to claim 7, wherein the reaction temperature ranges from 0 to 30°C.
11. The process according to claim 1, wherein the reactions of steps A and B of Scheme 3 are carried out in sequence, without isolating the intermediate (VIII) , in an organic solvent, in the presence of a tertiary or- ganic base, at a temperature ranging from -65°C to the boiling point of the solvent used. 12. The process according to claim 11, wherein the solvent is selected from the group consisting of dichlo- romethane, ethyl acetate, tetrahydrofuran. 13. The process according to claim 11, wherein the organic base is selected from the group consisting of N- methylmorpholine, N-ethylmorpholine, N-methylthio- orpholine, N-ethylthiomorpholine.
14. The process according to claim 11, wherein the reaction temperature ranges from 0 to 30°C.
15. The process according to claim 11, wherein the reactions of steps A and B are carried out in an aqueous medium, in the presence of an inorganic base and optionally a co-solvent, or a buffer at pH 10 and at a temperature ranging from -65°C to the boiling point of the solvent used.
16. The process according to claim 15, wherein the co- solvent is selected from the group consisting of dichloromethane, ethyl acetate, tetrahydrofuran; the base is selected from the group consisting of potassium carbonate, sodium hydroxide; the buffer at pH 10 consists of potassium borate; the operating temperature ranges from 0 to 30°C.
17. The process according to claim 11, wherein the reac- tions of steps A and B are carried out directly in the medium in which the oxazolidinedione having formula (VI) was prepared, without isolating it.
PCT/EP2001/007067 2000-07-13 2001-06-21 Process for the preparation of dipeptide derivatives WO2002006304A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001270584A AU2001270584A1 (en) 2000-07-13 2001-06-21 Process for the preparation of dipeptide derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2000A001578 2000-07-13
IT2000MI001578A IT1318623B1 (en) 2000-07-13 2000-07-13 PROCEDURE FOR THE PREPARATION OF DIPEPTIDIC DERIVATIVES.

Publications (1)

Publication Number Publication Date
WO2002006304A1 true WO2002006304A1 (en) 2002-01-24

Family

ID=11445461

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007067 WO2002006304A1 (en) 2000-07-13 2001-06-21 Process for the preparation of dipeptide derivatives

Country Status (3)

Country Link
AU (1) AU2001270584A1 (en)
IT (1) IT1318623B1 (en)
WO (1) WO2002006304A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015141867A1 (en) 2014-03-20 2015-09-24 Mitsui Chemicals Agro, Inc. Plant disease control composition and method for controlling plant disease by application of same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0943621A2 (en) * 1998-02-09 1999-09-22 P.F.C. Italiana S.r.l. Process for the production of alkoxycarbonylpeptides intermediates in the synthesis of the lisinopril
EP1028125A1 (en) * 1998-11-30 2000-08-16 Isagro Ricerca S.r.l. Dipeptide compounds having fungicidal activity and their agronomic use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0943621A2 (en) * 1998-02-09 1999-09-22 P.F.C. Italiana S.r.l. Process for the production of alkoxycarbonylpeptides intermediates in the synthesis of the lisinopril
EP1028125A1 (en) * 1998-11-30 2000-08-16 Isagro Ricerca S.r.l. Dipeptide compounds having fungicidal activity and their agronomic use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HIRSCHMANN R ET AL: "THE CONTROLLED SYNTHESIS OF PEPTIDES IN AQUEOUS MEDIUM. VIII. THE PREPARATION AND USE OF NOVEL ALPHA-AMINO ACID N-CARBOXYANHYDRIDES", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 93, no. 11, June 1971 (1971-06-01), pages 2746 - 2754, XP000914892, ISSN: 0002-7863 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015141867A1 (en) 2014-03-20 2015-09-24 Mitsui Chemicals Agro, Inc. Plant disease control composition and method for controlling plant disease by application of same

Also Published As

Publication number Publication date
ITMI20001578A1 (en) 2002-01-13
IT1318623B1 (en) 2003-08-27
AU2001270584A1 (en) 2002-01-30
ITMI20001578A0 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
EP0713868B1 (en) Process for the manufacture of insecticidal arylpyrroles via oxazole amine intermediates
US20080188667A1 (en) Azlactone compound and method for preparation thereof
WO2002006304A1 (en) Process for the preparation of dipeptide derivatives
NO166712B (en) PROCEDURE FOR THE PREPARATION OF PYRROLIDO DERIVATIVES.
EP1586552B1 (en) Process for producing benzylamine derivative
KR100369274B1 (en) Improved process for producing 4-hydroxy-2-pyrrolidone
JP3004957B2 (en) Method for producing sulfonyl chloride derivative
AU708059C (en) An arthropodicidal oxadiazine intermediate
KR20030017473A (en) One-pot synthesis of alkyl 3-cyclopropylamino-2-[2,4-dibromo-3-(difluoromethoxy)benzoyl]-2-propenoate as a useful intermediate for antibacterial quinolone medicaments
EP0739885B1 (en) Process for producing 3-isoxazolecarboxylic acid
CA2328723A1 (en) Improved process for the manufacture of n-(1-cyanoalkyl)-2-phenoxypropionamide derivatives
RU2804663C2 (en) Method of producing two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-il} butanoyl]amino}-2-fluorobenzamide derivatives
NO179903B (en) Process for the preparation of a haloacetamide derivative and a pyrrolidinylacetamide derivative
EP0413832A1 (en) Oxazolidinedione derivatives and production thereof
JPH09132554A (en) Production of 4-alkoxy-1,1,1-trifluoro-3-buten-2-one
JP2023111473A (en) Production method of cyclization product formed by cyclization reaction involving dehydration condensation, and production method of 1,3,4-substituted pyrazole-5-carboxylic acid ester
JP3780436B2 (en) Process for producing α-tetrasubstituted phthalocyanine
KR100212636B1 (en) New process for preparing herbicidal pyrimidyloxybenzoic acid oxime ester derivatives
JPH09124610A (en) 1,2-diformylhexahydropyridazine, its production and production of hexahydropyridazine
JP4172931B2 (en) Process for producing 1-alkyl-5-hydroxypyrazole
KR100343551B1 (en) Process for preparing 4-alkoxycarbonyl-5-chloropyrazole derivatives
EP0064797B1 (en) N-diarylmethyl-3-amino-4-alkenaryl-2-azetidinones and their preparation
Wagner et al. The (2-phenyl-2-trimethylsilyl) ethoxycarbonyl (Psoc) group-A novel amino protecting group
CA2342807A1 (en) Production method of oxazole compound
KR900007314B1 (en) Process for preparing n-(methoxyacetyl)-n-(2,l-dimethyl phenyl)-o-amino-oxazolidine-2-one

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP